These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 36104718)

  • 1. Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow.
    Xiong F; Wang Q; Wu GH; Liu WZ; Wang B; Chen YJ
    Biomark Res; 2022 Sep; 10(1):69. PubMed ID: 36104718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.
    Vyas K; Brassard DL; DeLorenzo MM; Sun Y; Grace MJ; Borden EC; Leaman DW
    J Immunother; 2003; 26(3):202-11. PubMed ID: 12806274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.
    Tsuno T; Mejido J; Zhao T; Schmeisser H; Morrow A; Zoon KC
    J Immunother; 2009 Oct; 32(8):803-16. PubMed ID: 19752753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.
    Flori N; Funakoshi N; Duny Y; Valats JC; Bismuth M; Christophorou D; Daurès JP; Blanc P
    Drugs; 2013 Mar; 73(3):263-77. PubMed ID: 23436591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice.
    Roh MR; Zheng Z; Kim HS; Jeung HC; Rha SY; Chung KY
    Melanoma Res; 2013 Apr; 23(2):114-24. PubMed ID: 23358428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
    Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
    J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
    Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.
    Grace MJ; Lee S; Bradshaw S; Chapman J; Spond J; Cox S; Delorenzo M; Brassard D; Wylie D; Cannon-Carlson S; Cullen C; Indelicato S; Voloch M; Bordens R
    J Biol Chem; 2005 Feb; 280(8):6327-36. PubMed ID: 15596441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a single amino acid substitution at position 79 of human IFN-α2b in interferon-receptor assembly and activity.
    Talebi S; Saeedinia A; Zeinoddini M; Ahmadpour F; Sadeghizadeh M
    Prep Biochem Biotechnol; 2019; 49(8):735-743. PubMed ID: 31135267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field production and functional evaluation of chloroplast-derived interferon-alpha2b.
    Arlen PA; Falconer R; Cherukumilli S; Cole A; Cole AM; Oishi KK; Daniell H
    Plant Biotechnol J; 2007 Jul; 5(4):511-25. PubMed ID: 17490449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-beta compared with IFN-alpha.
    Grumbach IM; Fish EN; Uddin S; Majchrzak B; Colamonici OR; Figulla HR; Heim A; Platanias LC
    J Interferon Cytokine Res; 1999 Jul; 19(7):797-801. PubMed ID: 10454351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glycosylated human interferon alpha 2b expressed in glycoengineered Pichia pastoris and its biological activity: N-linked glycoengineering approach.
    Katla S; Yoganand KNR; Hingane S; Ranjith Kumar CT; Anand B; Sivaprakasam S
    Enzyme Microb Technol; 2019 Sep; 128():49-58. PubMed ID: 31186110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Interferon Combined with Thalidomid on HEL Cell Apoptosis and JAK2V617F Mutation Gene Expression].
    Wu XX; Xue LG; Zhao LD; Wang Y; Cai ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):998-1002. PubMed ID: 27531763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.
    Ceballos MP; Parody JP; Quiroga AD; Casella ML; Francés DE; Larocca MC; Carnovale CE; Alvarez Mde L; Carrillo MC
    J Interferon Cytokine Res; 2014 Nov; 34(11):858-69. PubMed ID: 24950290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel interferon-α2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro.
    Fukui N; Kageyama Y; Higashi Y; Kihara K; Kizaka-Kondoh S; Hiraoka M; Shinojima T; Suzuki K; Oya M
    Int J Clin Oncol; 2014; 19(3):497-504. PubMed ID: 23739923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
    Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
    J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonist peptides of human interferon-alpha2b isolated from phage display library inhibit interferon induced antiviral activity.
    Tian W; Bai G; Li ZH; Yang WB
    Acta Pharmacol Sin; 2006 Aug; 27(8):1044-50. PubMed ID: 16867257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.